BD2 domain selective BET inhibitor
oral efficacy in 3 inflammation models
from SBDD of a BD2-selective HTS hit
Science, Mar. 19, 2020
GlaxoSmithKline, Stevenage, UK
GSK620
1 min read
GSK620 (GlaxoSmithKline (GSK) oral in vivo BD2 domain selective BET inhibitor)
Search By Structure
- CC-92480
- “PROTAC 6”
- GSK620
- Merck hArg1 inhibitor
- Merck IDO1 inhibitor
- Constellation EZH2 inhibitor
- Arcus CD73 inhibitor
- MK-6884
- Sulfopin
- M3814
- Remibrutinib
Molecules of the Month
2023
2022
2021
2020